TY - JOUR
T1 - Multicentre external validation of the prognostic model kidney failure risk equation in patients with CKD stages 3 and 4 in Peru
T2 - a retrospective cohort study
AU - Bravo-Zúñiga, Jessica
AU - Chávez-Gómez, Ricardo
AU - Soto-Becerra, Percy
N1 - Publisher Copyright:
© 2024 BMJ Publishing Group. All rights reserved.
PY - 2024/1/6
Y1 - 2024/1/6
N2 - Objectives To externally validate the four-variable kidney failure risk equation (KFRE) in the Peruvian population for predicting kidney failure at 2 and 5 years. Design A retrospective cohort study. Setting 17 primary care centres from the Health's Social Security of Peru. Participants Patients older than 18 years, diagnosed with chronic kidney disease stage 3a-3b-4 and 3b-4, between January 2013 and December 2017. Patients were followed until they developed kidney failure, died, were lost, or ended the study (31 December 2019), whichever came first. Primary and secondary outcome measures Performance of the KFRE model was assessed based on discrimination and calibration measures considering the competing risk of death. Results We included 7519 patients in stages 3a-4 and 2798 patients in stages 3b-4. The estimated cumulative incidence of kidney failure, accounting for competing event of death, at 2 years and 5 years, was 1.52% and 3.37% in stages 3a-4 and 3.15% and 6.86% in stages 3b-4. KFRE discrimination at 2 and 5 years was high, with time-dependent area under the curve and C-index >0.8 for all populations. Regarding calibration in-the-large, the observed to expected ratio and the calibration intercept indicated that KFRE underestimates the overall risk at 2 years and overestimates it at 5 years in all populations. Conclusions The four-variable KFRE models have good discrimination but poor calibration in the Peruvian population. The model underestimates the risk of kidney failure in the short term and overestimates it in the long term. Further research should focus on updating or recalibrating the KFRE model to better predict kidney failure in the Peruvian context before recommending its use in clinical practice.
AB - Objectives To externally validate the four-variable kidney failure risk equation (KFRE) in the Peruvian population for predicting kidney failure at 2 and 5 years. Design A retrospective cohort study. Setting 17 primary care centres from the Health's Social Security of Peru. Participants Patients older than 18 years, diagnosed with chronic kidney disease stage 3a-3b-4 and 3b-4, between January 2013 and December 2017. Patients were followed until they developed kidney failure, died, were lost, or ended the study (31 December 2019), whichever came first. Primary and secondary outcome measures Performance of the KFRE model was assessed based on discrimination and calibration measures considering the competing risk of death. Results We included 7519 patients in stages 3a-4 and 2798 patients in stages 3b-4. The estimated cumulative incidence of kidney failure, accounting for competing event of death, at 2 years and 5 years, was 1.52% and 3.37% in stages 3a-4 and 3.15% and 6.86% in stages 3b-4. KFRE discrimination at 2 and 5 years was high, with time-dependent area under the curve and C-index >0.8 for all populations. Regarding calibration in-the-large, the observed to expected ratio and the calibration intercept indicated that KFRE underestimates the overall risk at 2 years and overestimates it at 5 years in all populations. Conclusions The four-variable KFRE models have good discrimination but poor calibration in the Peruvian population. The model underestimates the risk of kidney failure in the short term and overestimates it in the long term. Further research should focus on updating or recalibrating the KFRE model to better predict kidney failure in the Peruvian context before recommending its use in clinical practice.
KW - Chronic renal failure
KW - Dialysis
KW - End stage renal failure
KW - Prognosis
UR - http://www.scopus.com/inward/record.url?scp=85181845669&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2023-076217
DO - 10.1136/bmjopen-2023-076217
M3 - Original Article
C2 - 38184316
AN - SCOPUS:85181845669
SN - 2044-6055
VL - 14
JO - BMJ Open
JF - BMJ Open
IS - 1
M1 - e076217
ER -